Discordant effect of IFN-beta1a therapy on anti-IFN antibodies and thyroid disease development in patients with multiple sclerosis.
暂无分享,去创建一个
L. Murri | C. Scagnolari | G. Antonelli | E. Ferrannini | A. Casolaro | F. Monzani | F. Bruschi | F. Lombardo | G. Meucci | N. Caraccio | M. Saviozzi | G. Moscato | S. Mosti